Communication
Kefayati et al.
of [BMIm]HSO4:20 1-buthyl-3-methyimidazolium hydrogen sul-
fate was obtained by a dropwise addition of one equivalent of
concentrated sulphuric acid (98%) to solution of 1-butyl-3-meth-
ylimidazolium bromide in anhydrous methylene chloride. The re-
action proceed at room temperature for 24 h with vigorous stir-
ring. Then, the mixture was dried in vacuum by a rotary evapora-
tor to remove the HBr and solvent to obtain the viscous clear
[BMIm]HSO4.
6.68-6.70 (m, 2H), 6.89-6.91 (m, 2H), 6.99-7.07 (m, 4H), 7.30-
7.38 (m, 2H), 7.52 (d, J = 7.44 Hz, 1H), 8.07 (d, J = 7.76 Hz, 1H)
ppm; 13C NMR (125.75 MHz, DMSO-d6): d 15.0, 27.5, 29.6,
77.2, 110.6, 114.3, 114.5, 117.8, 122.1, 126.2, 127.3, 127.6,
129.0, 129.4, 130.6, 133.3, 135.8, 141.2, 142.8, 146.1, 163.6,
174.3 ppm. Anal. Calcd for C24H21N3O2: C, 75.18; H, 5.52; N,
10.96. Found: C, 75.24; H, 5.57; N, 10.90.
General Experimental Procedure for the Preparation of
Compounds 4a-o. A mixture of isatoic anhydrid (1 mmol), aro-
matic amines (1.2 mmol), isatin derivatives21 (1 mmol), ionic liq-
uid [HMIm][HSO4] (0.5 mmol) was heated in an oil bath at 100 ºC
for the appropriate times according to Table 2. After completion
of reaction, as indicated by TLC, 20 mL distilled water was
added, then the resulting solid product was filtered and dried. The
crude product was recrystallized from ethanol and dried to afford
powder compounds of 4a-o.
ACKNOWLEDGMENTS
We are grateful to the Islamic Azad University, Rasht
Branch for financial support of this work.
REFERENCES
1. Hour, M.; Huang, L.; Kuo, S.; Xia, Y.; Bastow, K.; Nakanishi,
Y.; Hamel, E.; Lee, K. J. Med. Chem. 2000, 43, 4479-4487.
2. (a) Hori, M.; Iemura, R.; Hara, H.; Ozaki, A. Chem. Pharm.
Bull. 1990, 38, 1286-1291; (b) Bonola, G.; Sianesi, E. J.
Med. Chem. 1970, 13, 329-332.
3-(o-Chlorophenyl)-1H-spiro[indoline-3¢,2-quinazo-
line]-2¢,4(3H)-dione (4b). Yield: 87%, Beige powder; mp 293-
295 °C. IR (KBr): nmax 1477, 1618, 1741, 3072, 3352, 3458 cm-1.
1H NMR (500 MHz, DMSO-d6): d 6.70 (d, J = 7.79 Hz, 1H), 6.73
(d, J = 8.06 Hz, 1H), 6.76 (t, J = 7.50 Hz, 1H), 6.88 (t, J = 7.50 Hz,
1H), 7.01-7.03 (m, 1H), 7.15-7.22 (m, 3H), 7.32 (t, J = 7.20 Hz,
1H), 7.40-7.43 (m, 1H), 7.51 (d, J = 7.41 Hz, 1H), 7.66-7.67 (m,
2H), 10.6 (s, 1H, NH) ppm; 13C NMR (125 MHz, DMSO-d6): d
77.0, 111.0, 115.2, 115.5, 118.6, 122.9, 126.2, 126.9, 128.3,
128.7, 128.8, 130.3, 130.6, 132.1, 134.0, 134.6, 137.1, 142.8,
147.1, 163.4, 176.7 ppm. Anal. Calcd for C21H14ClN3O2: C,
67.12; H, 3.75; N, 11.18. Found: C, 67.07; H, 3.69; N, 11.21.
1¢-Benzyl-3-(m-chlorophenyl)-1H-spiro[indoline-3¢,2-
quinazoline]-2¢,4(3H)-dione (4k). Yield: 90%, Light yellow
powder, mp 222-224 ºC. IR (KBr): nmax 1479, 1612, 1641, 1728,
2927, 3058, 3248 cm-1. 1H NMR (500 MHz, DMSO-d6): d 4.48 (d,
J = 15.65 Hz, 1H), 4.95 (d, J = 15.65 Hz, 1H), 5.88 (brs, 1H, NH),
6.54 (d, J = 7.88 Hz, 1H), 6.69 (d, J = 8.02 Hz, 1H), 6.86-7.04 (m,
7H), 7.13-7.34 (m, 6H), 7.50 (d, J = 7.32 Hz, 1H), 7.94 (d, J = 7.94
Hz, 1H) ppm;13C NMR (125.75 MHz, DMSO-d6): d 44.3, 77.3,
110.3, 115.4, 116.2, 120.2, 123.8, 125.7, 127.5, 127.6, 128.2,
128.5, 128.8, 129.0, 129.2, 130.2, 130.4, 131.6, 134.5, 134.6,
135.0, 139.1, 142.4, 145.1, 164.5, 173.3 ppm. Anal. Calcd for
C28H20ClN3O2: C, 72.18; H, 4.33; N, 9.02. Found: C, 72.26; H,
4.27; N, 8.94.
3. (a) Rahimizadeh, M.; Tavallai, Z.; Bakavoli, M. Indian J.
Chem. Sec. B 2004, 43, 679-681; (b) Sadanadam, Y. S.;
Reddy, R. M.; Bhaskar, A. Eur. J. Med. Chem. 1987, 22, 169-
173.
4. Sundberg, R. J. The Chemistry of Indoles; Academic Press:
New York, 1996.
5. (a) Kang, T. H.; Matsumoto, K.; Murakami, Y.; Takayama,
H.; Kitajima, M.; Aimi, N.; Watanabe, H. Eur. J. Pharmacol.
2002, 444, 39-45; (b) Ma, J.; Hecht, S. M.; Javaniside, A.
Chem. Commun. 2004, 1190-1191; (c) Usui, T.; Kondoh, M.;
Cui, C. B.; Mayumi, T.; Osada, H.; Tryprostatin, A. Bio-
chem. J. 1998, 333, 543-548; (d) Khafagy, M. M.; El-Wahas,
A. H. F. A.; Eid, F. A.; El-Agrody, A. M. Farmaco 2002, 57,
715-722.
6. (a) Joshi, K. C.; Chand, P. Pharmazie 1982, 37, 1-12; (b)
Da-Silva, J. F. M.; Garden, S. J.; Pinto, A. C. J. Braz. Chem.
Soc. 2001, 12, 273-324; (c) Abdel-Rahman, A. H.; Keshk, E.
M.; Hanna, M. A.; El-Bady, Sh. M. Bioorg. Med. Chem.
2006, 12, 2483-2488; (d) Zhu, S. L.; Ji, S. J.; Yong, Z. Tetra-
hedron 2007, 63, 9365-9372.
7. (a) Welton, T. Chem. Rev. 1999, 99, 2071-2084. (b) Sheldon,
R. Chem. Commun. 2001, 23, 2399-2407. (c) Lee, J. K.;
Kim, M. J. J. Org. Chem. 2002, 67, 6845-6847. (d) Li, T. S.;
Zhang, Z. H.; Yang, F.; Fu, C. G. J. Chem. Res. 1998, 1, 38-
39.
8. Kefayati, H.; Rad-Moghadam, K.; Zamani, M.; Hosseyni, S.
Lett. Org. Chem. 2010, 7, 277-282.
9. (a) Kefatati, H.; Asghari, F.; Khanjanian, R. J. Mol. Liq.
2012, 172, 147–151; (b) Kefatati, H.; Narchin, F.; Rad-
Moghadam, K. Tetrahedron Lett. 2012, 53, 4573-4575.
10. Liu, J. F.; Lee, J.; Dalton, A. M.; Bi, G.; Yu, L.; Baldino, C.
M.; McElory, E.; Brown, M. Tetrahedron Lett. 2005, 46,
1241-1244.
1¢-Methyl-3-(p-ethylphenyl)-1H-spiro[indoline-3¢,2-
quinazoline]-2¢,4(3H)-dione (4n). Yield: 92%, Light yellow
powder, mp 232-235 ºC. IR (KBr): nmax 1512, 1614, 1641, 1726,
2982, 3056, 3282 cm-1. 1H NMR (500 MHz, DMSO-d6): d 1.16 (t,
J = 7.51 Hz, 3H), 2.54 (q, 2H), 3.06 (s, 3H), 4.58 (s, 1H, NH),
4
© 2013 The Chemical Society Located in Taipei & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
J. Chin. Chem. Soc. 2013, 60, 000-000